H.C. Wainwright Starts OncoMed Pharmaceuticals (OMED) at Buy

September 22, 2016 7:21 AM EDT Send to a Friend
H.C. Wainwright initiated coverage on OncoMed Pharmaceuticals (NASDAQ: OMED) with a Buy rating and a price target of $20. Analyst ...

To continue reading this article and more like it please sign-in or join today (FREE!)

Member Login